Fri, October 30, 2020
Thu, October 29, 2020
Wed, October 28, 2020
Tue, October 27, 2020
Mon, October 26, 2020
Fri, October 23, 2020

Colin Bristow Initiated (BIIB) at Hold and Held Target at $268 on, Oct 28th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-268-on-oct-28th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Colin Bristow of UBS, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $268 on, Oct 28th, 2020.

Colin has made no other calls on BIIB in the last 4 months.



There are 8 other peers that have a rating on BIIB. Out of the 8 peers that are also analyzing BIIB, 4 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $282 on, Tuesday, October 27th, 2020
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020


These are the ratings of the 4 analyists that currently disagree with Colin


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Geoff Meacham of "B of A Securities" Maintained at Sell with Decreased Target to $235 on, Thursday, October 15th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020

Publication Contributing Sources